DNA hypomethylation and activation of germline-specific genes in cancer

Advances in Experimental Medicine and Biology

Volumn 754, Issue , 2013, Pages 149-166

  De Smet, Charles ^a   Loriot, Axelle ^a  

^a DE DUVE INSTITUTE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; ANTINEOPLASTIC AGENT; CANCER VACCINE; CYTOSINE; EPIGENETIC DRUG; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GENETICS; CANCER IMMUNOTHERAPY; CARCINOGENESIS; CG GENE; CPG ISLAND; CTAG1 GENE; DNA METHYLATION; EPIGENETICS; GENE ACTIVATION; GENE EXPRESSION; GERM LINE; MAGEA1 GENE; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE; PRIORITY JOURNAL; TRANSCRIPTION TERMINATION; TUMOR GENE; TUMOR IMMUNITY;

EID: 84869021480     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-9967-2_7     Document Type: Article

References (102)

1. Akers SN, Odunsi K, Karpf AR (2010) Regulation of cancer germline antigen gene expression: implications for cancer immunotherapy. Future Oncol 6(5):717-732
2. Almeida LG, Sakabe NJ, deOliveira AR, Silva MC, Mundstein AS, Cohen T, Chen YT, Chua R, Gurung S, Gnjatic S, Jungbluth AA, Caballero OL, Bairoch A, Kiesler E, White SL, Simpson AJ, Old LJ, Camargo AA, Vasconcelos AT (2009) CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens. Nucleic Acids Res 37(Database issue):D816-819
3. Antequera F, Boyes J, Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62(3):503-514
4. Bai S, He B, Wilson EM (2005) Melanoma antigen gene protein MAGE-11 regulates androgen receptor function by modulating the interdomain interaction. Mol Cell Biol 25(4):1238-1257 (Pubitemid 40204904)
5. Baylin SB, Herman JG, Graff JR, Vertino PM, Issa JP (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 72:141-196 (Pubitemid 27435555)
6. Bestor TH (2000) The DNA methyltransferases of mammals. Hum Mol Genet 9(16):2395-2402
7. Bird AP (1980) DNA methylation and the frequency of CpG in animal DNA. Nucleic Acids Res 8:1499-1504
8. Bird A (2002) DNA methylation patterns and epigenetic memory. Genes Dev 16(1):6-21 (Pubitemid 34049633)
9. Boël P, Wildmann C, Sensi M-L, Brasseur R, Renauld J-C, Coulie P, Boon T, van der Bruggen P (1995) BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167-175
10. Boon T, Cerottini J-C, Van den Eynde B, van der Bruggen P, Van Pel A (1994) Tumor antigens recognized by T lymphocytes. Annu Rev Immunol 12:337-365 (Pubitemid 24140418)
11. Boon T, Coulie PG, Van den Eynde BJ, van der Bruggen P (2006) Human T cell responses against melanoma. Annu Rev Immunol 24:175-208
12. Boyes J, Bird A (1992) Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 11(1):327-333
13. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H (1994) Sp1 elements protect a CpG island from de novo methylation. Nature 371(6496):435-438 (Pubitemid 24302561)
14. Cadieux B, Ching TT, VandenBerg SR, Costello JF (2006) Genome-wide hypomethylation in human glioblastomas associated with speci fi c copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation. Cancer Res 66(17):8469-8476 (Pubitemid 44449159)
15. Cedar H, Bergman Y (2009) Linking DNA methylation and histone modi fi cation: patterns and paradigms. Nat Rev Genet 10(5):295-304
16. Chen ZX, Riggs AD (2011) DNA methylation and demethylation in mammals. J Biol Chem 286(21):18347-18353
17. Cho B, Lee H, Jeong S, Bang YJ, Lee HJ, Hwang KS, Kim HY, Lee YS, Kang GH, Jeoung DI (2003) Promoter hypomethylation of a novel cancer/testis antigen gene CAGE is correlated with its aberrant expression and is seen in premalignant stage of gastric carcinoma. Biochem Biophys Res Commun 307(1):52-63 (Pubitemid 36808535)
18. Cilensek ZM, Yehiely F, Kular RK, Deiss LP (2002) A member of the GAGE family of tumor antigens is an anti-apoptotic gene that confers resistance to Fas/CD95/APO-1, Interferongamma, taxol and gamma-irradiation. Cancer Biol Ther 1(4):380-387
19. Cross SH, Bird AP (1995) CpG islands and genes. Curr Opin Genet Dev 5:309-314
20. De Plaen E, Arden K, Traversari C, Gaforio JJ, Szikora J-P, De Smet C, Brasseur F, van der Bruggen P, Lethé B, Lurquin C, Brasseur R, Chomez P, De Backer O, Cavenee W, Boon T (1994) Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 40:360-369 (Pubitemid 24299325)
21. De Plaen E, Naerhuyzen B, De Smet C, Szikora J-P, Boon T (1997) Alternative promoters of gene MAGE4a. Genomics 40:305-313 (Pubitemid 27124093)
22. De Smet C, Loriot A (2010) DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics 5(3):206-213
23. De Smet C, Lurquin C, van der Bruggen P, De Plaen E, Brasseur F, Boon T (1994) Sequence and expression pattern of the human MAGE2 gene. Immunogenetics 39:121-129 (Pubitemid 23344813)
24. De Smet C, Courtois SJ, Faraoni I, Lurquin C, Szikora JP, De Backer O, Boon T (1995) Involvement of two Ets binding sites in the transcriptional activation of the MAGE1 gene. Immunogenetics 42(4):282-290
25. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 93(14):7149-7153 (Pubitemid 26243517)
26. De Smet C, Lurquin C, Lethé B, Martelange V, Boon T (1999) DNA methylation is the primary silencing mechanism for a set of germ line- and tumor-speci fi c genes with a CpG-rich promoter. Mol Cell Biol 19:7327-7335 (Pubitemid 29493396)
27. De Smet C, Loriot A, Boon T (2004) Promoter-dependent mechanism leading to selective hypomethylation within the 5′ region of gene MAGE-A1 in tumor cells. Mol Cell Biol 24(11):4781-4790 (Pubitemid 38668044)
28. Doyle JM, Gao J, Wang J, Yang M, Potts PR (2010) MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases. Mol Cell 39(6):963-974
29. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400-5413 (Pubitemid 34983477)
30. Feinberg AP, Gehrke CW, Kuo KC, Ehrlich M (1988) Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res 48(5):1159-1161 (Pubitemid 18075525)
31. Felsenfeld G, Groudine M (2003) Controlling the double helix. Nature 421(6921):448-453 (Pubitemid 36157954)
32. Flatau E, Gonzales FA, Michalowsky LA, Jones PA (1984) DNA methylation in 5-aza-2′ - deoxycytidine-resistant variants of C3H 10T1/2C18 cells. Mol Cell Biol 4(10):2098-2102 (Pubitemid 15209982)
33. Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300(5618):489-492 (Pubitemid 36444330)
34. Gaugler B, Van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, De Plaen E, Lethé B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for an antigen recognized on a melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921-930 (Pubitemid 24065650)
35. Goodyear O, Agathanggelou A, Novitzky-Basso I, Siddique S, McSkeane T, Ryan G, Vyas P, Cavenagh J, Stankovic T, Moss P, Craddock C (2010) Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia. Blood 116(11):1908-1918
36. Grunwald C, Koslowski M, Arsiray T, Dhaene K, Praet M, Victor A, Morresi-Hauf A, Lindner M, Passlick B, Lehr HA, Schafer SC, Seitz G, Huber C, Sahin U, Tureci O (2006) Expression of multiple epigenetically regulated cancer/germline genes in nonsmall cell lung cancer. Int J Cancer 118(10):2522-2528
37. Haas GG Jr, D'Cruz OJ, De Bault LE (1988) Distribution of human leukocyte antigen-ABC and -D/DR antigens in the un fi xed human testis. Am J Reprod Immunol Microbiol 18(2):47-51 (Pubitemid 19020259)
38. Hoffmann MJ, Muller M, Engers R, Schulz WA (2006) Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies. Biochem Pharmacol 72(11):1577-1588 (Pubitemid 44666737)
39. Holliday R, Pugh JE (1975) DNA modi fi cation mechanisms and gene activity during development. Science 186:226-232
40. Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, Fischette MR, Adnani MT, Loukinov DI, Vatolin S, Risinger JI, Custer M, Chen GA, Zhao M, Nguyen DM, Barrett JC, Lobanenkov VV, Schrump DS (2005) Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res 65(17):7763-7774 (Pubitemid 41297251)
41. Jackson K, Yu MC, Arakawa K, Fiala E, Youn B, Fiegl H, Muller-Holzner E, Widschwendter M, Ehrlich M (2004) DNA hypomethylation is prevalent even in low-grade breast cancers. Cancer Biol Ther 3(12):1225-1231 (Pubitemid 41350957)
42. James SR, Link PA, Karpf AR (2006) Epigenetic regulation of X-linked cancer/germline antigen genes by DNMT1 and DNMT3b. Oncogene 25(52):6975-6985 (Pubitemid 44684838)
43. Jones PA, Wolkowicz MJ, Rideout WM III, Gonzales FA, Marziasz CM, Coetzee GA, Tapscott SJ (1990) De novo methylation of the MyoD1 CpG island during the establishment of immortal cell lines. Proc Natl Acad Sci USA 87(16):6117-6121
44. Jungbluth AA, Chen YT, Stockert E, Busam KJ, Kolb D, Iversen K, Coplan K, Williamson B, Altorki N, Old LJ (2001) Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues. Int J Cancer 92(6):856-860 (Pubitemid 32467376)
45. Kaneda A, Tsukamoto T, Takamura-Enya T, Watanabe N, Kaminishi M, Sugimura T, Tatematsu M, Ushijima T (2004) Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 95(1):58-64 (Pubitemid 38208408)
46. Kang Y, Hong JA, Chen GA, Nguyen DM, Schrump DS (2007) Dynamic transcriptional regulatory complexes including BORIS, CTCF and Sp1 modulate NY-ESO-1 expression in lung cancer cells. Oncogene 26(30):4394-4403 (Pubitemid 47014459)
47. Karpf AR, Lasek AW, Ririe TO, Hanks AN, Grossman D, Jones DA (2004) Limited gene activation in tumor and normal epithelial cells treated with the DNA methyltransferase inhibitor 5-aza-2′ -deoxycytidine. Mol Pharmacol 65(1):18-27 (Pubitemid 38113882)
48. Karpf AR, Bai S, James SR, Mohler JL, Wilson EM (2009) Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP. Mol Cancer Res 7(4):523-535
49. Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C (2008) Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Int J Cancer 122(4):777-784
50. Khong HT, Wang QJ, Rosenberg SA (2004) Identi fi cation of multiple antigens recognized by tumor-in fi ltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression. J Immunother 27(3):184-190 (Pubitemid 39118082)
51. Kondo T, Zhu X, Asa SL, Ezzat S (2007) The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fi broblast growth factor receptor 2-IIIb through histone H3 modi fi cations in thyroid cancer. Clin Cancer Res 13(16):4713-4720 (Pubitemid 47294777)
52. Koslowski M, Bell C, Seitz G, Lehr HA, Roemer K, Muntefering H, Huber C, Sahin U, Tureci O (2004) Frequent nonrandom activation of germ-line genes in human cancer. Cancer Res 64(17):5988-5993 (Pubitemid 39129395)
53. Lin CH, Hsieh SY, Sheen IS, Lee WC, Chen TC, Shyu WC, Liaw YF (2001) Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 61(10):4238-4243
54. Link PA, Gangisetty O, James SR, Woloszynska-Read A, Tachibana M, Shinkai Y, Karpf AR (2009) Distinct roles for histone methyltransferases G9a and GLP in cancer germ-line antigen gene regulation in human cancer cells and murine embryonic stem cells. Mol Cancer Res 7(6):851-862
55. Lorincz MC, Schubeler D, Goeke SC, Walters M, Groudine M, Martin DI (2000) Dynamic analysis of proviral induction and de novo methylation: implications for a histone deacetylase- independent, methylation density-dependent mechanism of transcriptional repression. Mol Cell Biol 20(3):842-850 (Pubitemid 30044221)
56. Loriot A, Boon T, De Smet C (2003) Five new human cancer-germline genes identi fi ed among 12 genes expressed in spermatogonia. Int J Cancer 105(3):371-376 (Pubitemid 36570050)
57. Loriot A, De Plaen E, Boon T, De Smet C (2006) Transient down-regulation of DNMT1 methyltransferase leads to activation and stable hypomethylation of MAGE-A1 in melanoma cells. J Biol Chem 281(15):10118-10126 (Pubitemid 43864547)
58. Loriot A, Sterpin C, De Backer O, De Smet C (2008) Mouse embryonic stem cells induce targeted DNA demethylation within human MAGE-A1 transgenes. Epigenetics 3(1):38-42 (Pubitemid 351540962)
59. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, Chernukhin I, Mannan P, Larsson E, Kanduri C, Vostrov AA, Cui H, Niemitz EL, Rasko JE, Docquier FM, Kistler M, Breen JJ, Zhuang Z, Quitschke WW, Renkawitz R, Klenova EM, Feinberg AP, Ohlsson R, Morse HC III, Lobanenkov VV (2002) BORIS, a novel male germ-line-speci fi c protein associated with epigenetic reprogramming events, shares the same 11-zinc- fi nger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 99(10):6806-6811 (Pubitemid 34526213)
60. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T (1998) Identi fi cation of a new MAGE gene with tumor-speci fi c expression by representational difference analysis. Cancer Res 58(4):743-752 (Pubitemid 28099487)
61. Lurquin C, De Smet C, Brasseur F, Muscatelli F, Martelange V, De Plaen E, Brasseur R, Monaco AP, Boon T (1997) Two members of the human MAGEB gene family located in Xp21.3 are expressed in tumors of various histological origins. Genomics 46(3):397-408 (Pubitemid 28063288)
62. Macleod D, Charlton J, Mullins J, Bird AP (1994) Sp1 sites in the mouse aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev 8(19):2282-2292 (Pubitemid 24314290)
63. Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T (2000) Identi fi cation on a human sarcoma of two new genes with tumor-speci fi c expression. Cancer Res 60(14):3848-3855 (Pubitemid 32204577)
64. Monte M, Simonatto M, Peche LY, Bublik DR, Gobessi S, Pierotti MA, Rodolfo M, Schneider C (2006) MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci USA 103(30):11160-11165 (Pubitemid 44156489)
65. Nagao T, Higashitsuji H, Nonoguchi K, Sakurai T, Dawson S, Mayer RJ, Itoh K, Fujita J (2003) MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem 278(12):10668-10674 (Pubitemid 36800336)
66. Novak P, Jensen T, Oshiro MM, Watts GS, Kim CJ, Futscher BW (2008) Agglomerative epigenetic aberrations are a common event in human breast cancer. Cancer Res 68(20):8616-8625
67. Novak P, Jensen TJ, Garbe JC, Stampfer MR, Futscher BW (2009) Stepwise DNA methylation changes are linked to escape from defined proliferation barriers and mammary epithelial cell immortalization. Cancer Res 69(12):5251-5258
68. Oikawa T, Yamada T (2003) Molecular biology of the Ets family of transcription factors. Gene 303:11-34 (Pubitemid 36151767)
69. Peikert T, Specks U, Farver C, Erzurum SC, Comhair SA (2006) Melanoma antigen A4 is expressed in non-small cell lung cancers and promotes apoptosis. Cancer Res 66(9): 4693-4700
70. Rao M, Chinnasamy N, Hong JA, Zhang Y, Zhang M, Xi S, Liu F, Marquez VE, Morgan RA, Schrump DS (2011) Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer. Cancer Res 71(12):4192-4204
71. Rauch TA, Zhong X, Wu X, Wang M, Kernstine KH, Wang Z, Riggs AD, Pfeifer GP (2008) High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA 105(1):252-257
72. Riggs AD (1989) DNA methylation and cell memory. Cell Biophys 15(1-2):1-13
73. Sahin U, Tureci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M (1995) Human neoplasms elicit multiple speci fi c immune responses in the autologous host. Proc Natl Acad Sci USA 92:11810-11813 (Pubitemid 26014201)
74. Sahin U, Tureci O, Chen YT, Seitz G, Villena-Heinsen C, Old LJ, Pfreundschuh M (1998) Expression of multiple cancer/testis (CT) antigens in breast cancer and melanoma: basis for polyvalent CT vaccine strategies. Int J Cancer 78(3):387-389 (Pubitemid 28445380)
75. Scanlan MJ, Gordon CM, Williamson B, Lee SY, Chen YT, Stockert E, Jungbluth A, Ritter G, Jager D, Jager E, Knuth A, Old LJ (2002) Identi fi cation of cancer/testis genes by database mining and mRNA expression analysis. Int J Cancer 98(4):485-492 (Pubitemid 34208547)
76. Scanlan MJ, Simpson AJ, Old LJ (2004) The cancer/testis genes: review, standardization, and commentary. Cancer Immun 4:1
77. Shen L, Kondo Y, Guo Y, Zhang J, Zhang L, Ahmed S, Shu J, Chen X, Waterland RA, Issa JP (2007) Genome-wide pro fi ling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet 3(10):2023-2036
78. Sigalotti L, Coral S, Nardi G, Spessotto A, Cortini E, Cattarossi I, Colizzi F, Altomonte M, Maio M (2002) Promoter methylation controls the expression of MAGE2, 3 and 4 genes in human cutaneous melanoma. J Immunother 25(1):16-26 (Pubitemid 34052830)
79. Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ (2005) Cancer/testis antigens, gametogenesis and cancer. Nat Rev Cancer 5(8):615-625 (Pubitemid 41081387)
80. Suske G (1999) The Sp-family of transcription factors. Gene 238(2):291-300 (Pubitemid 29446168)
81. Swann JB, Smyth MJ (2007) Immune surveillance of tumors. J Clin Invest 117(5):1137-1146 (Pubitemid 46718398)
82. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K (1995) Identi fi cation of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55(16):3478-3482
83. Tilman G, Loriot A, Van Beneden A, Arnoult N, Londono-Vallejo JA, De Smet C, Decottignies A (2009) Subtelomeric DNA hypomethylation is not required for telomeric sister chromatid exchanges in ALT cells. Oncogene 28(14):1682-1693
84. Van den Eynde B, Peeters O, De Backer O, Gaugler B, Lucas S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689-698
85. van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B, Knuth A, Boon T (1991) A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254(5038):1643-1647 (Pubitemid 21917508)
86. Van Der Bruggen P, Zhang Y, Chaux P, Stroobant V, Panichelli C, Schultz ES, Chapiro J, Van Den Eynde BJ, Brasseur F, Boon T (2002) Tumor-speci fi c shared antigenic peptides recognized by human T cells. Immunol Rev 188(1):51-64 (Pubitemid 35398865)
87. Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, Loukinov DI, Pugacheva E, Hong JA, Morse H III, Schrump DS, Risinger JI, Barrett JC, Lobanenkov VV (2005) Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 65(17):7751-7762 (Pubitemid 41297250)
88. Walsh CP, Bestor TH (1999) Cytosine methylation and mammalian development. Genes Dev 13(1):26-34 (Pubitemid 29045113)
89. Wang Z, Zhang J, Zhang Y, Lim SH (2006) SPAN-Xb expression in myeloma cells is dependent on promoter hypomethylation and can be upregulated pharmacologically. Int J Cancer 118(6):1436-1444
90. Wang J, Emadali A, Le Bescont A, Callanan M, Rousseaux S, Khochbin S (2011) Induced malignant genome reprogramming in somatic cells by testis-speci fi c factors. Biochim Biophys Acta 1809(4-6):221-225
91. Weber J, Salgaller M, Samid D, Johnson B, Herlyn M, Lassam N, Treisman J, Rosenberg SA (1994) Expression of the MAGE-1 tumor antigen is up-regulated by the demethylating agent 5-aza-2′ -deoxycytidine. Cancer Res 54(7):1766-1771
92. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL, Schubeler D (2005) Chromosome-wide and promoter-speci fi c analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 37(8):853-862 (Pubitemid 41077111)
93. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M, Schubeler D (2007) Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 39(4):457-466 (Pubitemid 46514772)
94. Wilson VL, Jones PA (1983) DNA methylation decreases in aging but not in immortal cells. Science 220(4601):1055-1057 (Pubitemid 13090144)
95. Woloszynska-Read A, James SR, Link PA, Yu J, Odunsi K, Karpf AR (2007) DNA methylationdependent regulation of BORIS/CTCFL expression in ovarian cancer. Cancer Immun 7:21
96. Woloszynska-Read A, Mhawech-Fauceglia P, Yu J, Odunsi K, Karpf AR (2008) Intertumor and intratumor NY-ESO-1 expression heterogeneity is associated with promoter-speci fi c and global DNA methylation status in ovarian cancer. Clin Cancer Res 14(11):3283-3290
97. Woloszynska-Read A, James SR, Song C, Jin B, Odunsi K, Karpf AR (2010) BORIS/CTCFL expression is insuf fi cient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Cancer Immun 10:6
98. Yang B, O'Herrin SM, Wu J, Reagan-Shaw S, Ma Y, Bhat KM, Gravekamp C, Setaluri V, Peters N, Hoffmann FM, Peng H, Ivanov AV, Simpson AJ, Longley BJ (2007) MAGE-A, mMage-b, and MAGE-C proteins form complexes with KAP1 and suppress p53-dependent apoptosis in MAGE-positive cell lines. Cancer Res 67(20):9954-9962 (Pubitemid 47621245)
99. Yang B, Wu J, Maddodi N, Ma Y, Setaluri V, Longley BJ (2007) Epigenetic control of MAGE gene expression by the KIT tyrosine kinase. J Invest Dermatol 127(9):2123-2128 (Pubitemid 47258482)
100. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, De Marzo AM, Nelson WG (2008) DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Cancer Res 68(21):8954-8967
101. Yoder JA, Walsh CP, Bestor TH (1997) Cytosine methylation and the ecology of intragenomic parasites. Trends Genet 13(8):335-340 (Pubitemid 27309911)
102. Zhu X, Asa SL, Ezzat S (2008) Fibroblast growth factor 2 and estrogen control the balance of histone 3 modi fi cations targeting MAGE-A3 in pituitary neoplasia. Clin Cancer Res 14(7):1984-1996 (Pubitemid 351551107)